SCHEMBL512941

SCHEMBL512941

C[Si](C)(CCCC(=O)O)O[Si](C)(C)CCCC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.48
LMNA P02545 2/20 0.46
SLC22A6 Q4U2R8 2/20 0.46
NFKB1 P19838 1/20 0.43
PMP22 Q01453 1/20 0.43
AKR1B1 P15121 1/20 0.42
ALDH1A1 P00352 3/20 0.41
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
PTPN1 P18031 3/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7534254 0.98 TSHR (0.46) TSHRLMNASLC22A6NFKB1PMP22
Hydrochloric Acid SCHEMBL5368847 0.98 TSHR (0.46) TSHRLMNASLC22A6NFKB1PMP22
Azelaic Acid SCHEMBL8198302 0.96 TSHR (0.52) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL23908692 0.93 LMNA (0.50) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL20384010 0.91 TSHR (0.45) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL1054764 0.91 TSHR (0.52) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL18227327 0.90 TSHR (0.41) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL13038564 0.86 TSHR (0.41) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL513566 0.85 TSHR (0.41) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL18227341 0.85 CYP1A2 (0.47) TSHRAKR1B1ALDH1A1TDP1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106343-A1 ETCHING METHODS FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. (US) 2025-05-22 WO claimed
US-20250157825-A1 ETCHING METHODS FUJIFILM ELECTRONIC MATERIALS U.S.A., INC. 2025-05-15 US claimed
CN-118580480-B Organosilicon modified polyester polyol and preparation method and application thereof 中山市明逸化工新材料有限公司 2025-01-21 CN claimed
CN-119307086-A Scratch-resistant and wear-resistant overhead cable and production process thereof 中盛弘通电力科技有限公司 2025-01-14 CN claimed
CN-117737161-B Adiponectin antibody magnetic microsphere and adiponectin assay kit 广东优尼德生物科技有限公司 2025-01-03 CN claimed
CN-117761305-B Zinc transport protein 8 antibody detection kit and preparation method thereof 广东优尼德生物科技有限公司 2024-12-20 CN claimed
CN-118596725-B Decorative paper production process based on water-based ink gravure printing 浙江夏特新材料有限公司 2024-12-13 CN claimed
CN-118063999-B Temperature-resistant waterproof high-hardness ink for helmet and preparation method thereof 东莞市五人新材技术有限公司 2024-11-19 CN claimed
CN-117969824-B Functionalized magnetic microsphere, preparation method and tyrosine phosphatase antibody determination kit 广东优尼德生物科技有限公司 2024-11-08 CN claimed
CN-118596725-A Decorative paper production process based on water-based ink gravure printing 浙江夏特新材料有限公司 2024-09-06 CN claimed
US-7345000-B2 Method and system for treating a dielectric film TOKYO ELECTRON LIMITED (JP) 2008-03-18 US claimed
US-20070077782-A1 Treatment of low dielectric constant films using a batch processing system TOKYO ELECTRON LIMITED (JP) 2007-04-05 US claimed
US-20070077353-A1 Plasma-assisted vapor phase treatment of low dielectric constant films using a batch processing system TOKYO ELECTRON LIMITED (JP) 2007-04-05 US claimed
US-20070077781-A1 Plural treatment step process for treating dielectric films TOKYO ELECTRON LIMTED (JP) 2007-04-05 US claimed
US-7122491-B2 Method of increasing the lifetime of a hydro-oxidation catalyst DOW GLOBAL TECHNOLOGIES INC. (US) 2006-10-17 US claimed
EP-1453605-B1 METHOD OF INCREASING THE LIFETIME OF A HYDRO-OXIDATION CATALYST DOW GLOBAL TECHNOLOGIES INC (US) 2006-03-22 EP claimed
US-20050215072-A1 Method and system for treating a dielectric film TOKYO ELECTRON LIMITED (JP) 2005-09-29 US claimed
EP-1453605-A2 METHOD OF INCREASING THE LIFETIME OF A HYDRO-OXIDATION CATALYST DOW GLOBAL TECHNOLOGIES INC. (US) 2004-09-08 EP claimed
US-20040171893-A1 Method of increasing the lifetime of a hydro-oxidation catalyst THE DOW CHEMICAL COMPANY 2004-09-02 US claimed
WO-2003011454-A2 METHOD OF INCREASING THE LIFETIME OF A HYDRO-OXIDATION CATALYST DOW GLOBAL TECHNOLOGIES INC. (US) 2003-02-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171893-A1 Method of increasing the lifetime of a hydro-oxidation catalyst HAO2, HMOX2, TST TSHR 4382/4885LMNA 4763/4885SLC22A6 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.